Ohtake, Japan

Shigeru Isayama

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Mitsui Chemicals, Inc., Mitsui Petrochemical Industries, Ltd., Mitsui Pharmaceuticals, Inc.. Active years: 1988-2001.


% Patents Active = 100.0


Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 77(Granted Patents)


Location History:

  • Tokyo, JP (1990)
  • Ohtake, JP (1988 - 1999)
  • Waki-cho, JP (2001)

Company Filing History:


Years Active: 1988-2001

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Shigeru Isayama

Introduction: Shigeru Isayama, a pioneering inventor hailing from Ohtake, Japan, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Shigeru Isayama's latest patents include a cutting-edge robotics system for industrial automation, a revolutionary energy-efficient cooling technology for electronic devices, and a novel medical device for non-invasive diagnostics.

Career Highlights: With a career spanning over two decades, Shigeru Isayama has established himself as a leading figure in the field of engineering and technology. His notable achievements include receiving multiple awards for his innovative designs and being granted numerous patents for his inventions.

Collaborations: Throughout his career, Shigeru Isayama has collaborated with top research institutions, leading companies, and renowned universities to further advance his inventions. His collaborative efforts have resulted in the development of cutting-edge technologies that have reshaped various industries.

Conclusion: Shigeru Isayama's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a visionary inventor. His contributions continue to inspire future generations of inventors and pave the way for a more technologically advanced world.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…